Sold as Pavulon. Every FDA application for this active ingredient: 1 branded and 13 generic.
As of Nov 14, 2026, FDA lists 14 applications for Pancuronium Bromide (sold as Pavulon), first approved Oct 24, 1972, with 0 new uses approved and 0 published complete response letters.
| Study | Phase | Status | Posted |
|---|---|---|---|
| Erector Spinae Plane Block in Congenital Heart Disease PatientsCongenital Heart Disease in Children, Neurologic Complication · Stanford University | Not applicable | Not yet recruiting | Nov 8, 2019 |
| Oct 24, 1972 | PavulonNDA 17015 · New molecular entity | Organon USA Inc | 16 | Discontinued |
| Mar 23, 1988 | Pancuronium BromideANDA 72058 | Elkins Sinn | 9 | Discontinued |
| Mar 23, 1988 | Pancuronium BromideANDA 72059 | Elkins Sinn | 12 | Discontinued |
| Mar 23, 1988 | Pancuronium BromideANDA 72060 | Elkins Sinn | 11 | Discontinued |
| Jan 19, 1989 | Pancuronium BromideANDA 72320 | Hospira | 15 | Discontinued |
| Jan 19, 1989 | Pancuronium BromideANDA 72321 | Hospira | 5 | Discontinued |
| Jul 31, 1990 | Pancuronium BromideANDA 72759 | Dr Reddys | 7 | Marketed |
| Jul 31, 1990 | Pancuronium BromideANDA 72760 | Dr Reddys | 7 | Marketed |
| — | Pancuronium BromideANDA 72208 | Quad Pharms | 0 | Discontinued |
| — | Pancuronium BromideANDA 72209 | Quad Pharms | 0 | Discontinued |
| — | Pancuronium BromideANDA 72210 | Igi Labs Inc | 0 | Discontinued |
| — | Pancuronium BromideANDA 72211 | Igi Labs Inc | 0 | Discontinued |
| — | Pancuronium BromideANDA 72212 | Igi Labs Inc | 0 | Discontinued |
| — | Pancuronium BromideANDA 72213 | Igi Labs Inc | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
